A plasmid is a small, circular, extrachromosomal, double-stranded deoxyribonucleic acid (DNA) molecule which is distinct from a cell’s chromosomal DNA. Plasmids are important vehicles for the communication of genetic information between bacteria. Plasmid is a genetic structure in a cell that can replicate independently of chromosomal DNA, and usually carry genes. The 21st century has witnessed a greater understanding and evolution of humans and diseases. This has brought about an increased potential and awareness of genomics of microbial plasmids, thereby supporting the plasmid market growth. According to an article published in the National Center for Biotechnology Information (NCBI), over the past six decades, a huge number of plasmids have been identified and isolated from various microbes. Due to revolution of sequencing technology, over 4,600 complete sequences of plasmids found in bacteria, eukaryotes, and archaea have been determined. The classification of plasmids has been helping to understand their host ranges, features, and microbial evolution as well as to efficiently use them as genetic tools for microbial engineering.
Access the Full Report @ https://www.absolutemarketsinsights.com/reports/Plasmid-Market-2019-2027-363
The global plasmid market was valued at US$ 89.52 million in 2020 and is estimated to reach US$ 447.68 million by 2029, growing at a CAGR of 19.5% over the forecast period from 2021 to 2029.
Worldwide rising prevalence of cancer, genetic diseases, and infectious diseases coupled with growing awareness about gene therapy is majorly driving growth of the global plasmid market. For instance, as per the data published by World Health Organization (WHO), the worldwide prevalence of all single gene (monogenic) diseases at birth is approximately 10 in 1,000 individuals currently. Plasmids find significance in the fields of gene therapy, oncology, and vaccines, among others. In addition, the presence of favorable government initiatives & grants and a growth in investment by private companies on R&D of plasmid deoxyribonucleic acid (DNA) are likely to catapult the market growth during the forecast period.
North America commanded the global plasmid market in 2018 attributed to the presence of prominent market players & biopharmaceutical manufacturers, growing awareness regarding gene therapy, and increasing investments in gene therapy products in the U.S. and Canada. On the other hand, surging number of susceptible population to various chronic diseases and wide availability of novel products providing improved healthcare to the patients at marginally lower costs in China and India are expected to contribute to the significant market growth of the Asia Pacific region.
The report provides both, qualitative and quantitative research of the global plasmid market. It is a definite source which provides penetrative insights into the rational scenario and favored manufacturing or production methods adopted by key market players based on the past and current scenario of the market. The report also provides extensive research on the key players in the market in addition to a comprehensive overview on their competitiveness. Key business strategies such as mergers and acquisitions (M&As), new product launches, collaborations, and partnerships adopted by the major players are also meticulously highlighted. For each company, the report recognizes their headquarters, competitors, product/service type, application and specification, pricing, and gross margin.
The primary market participants in the global plasmid market are Aldevron, GenScript, PlasmidFactory GmbH & Co. KG, VGXI, Inc., Oxford Genetics Ltd., Applied StemCell, Altogen Biosystems, Cobra Biologics, Copernicus Therapeutics, Inc., Takara Bio Inc., InvivoGen, Miltenyi Biotec, MaxCyte, Inc., Mirus Bio LLC, MolMed S.p.A., GenePharma Co., Ltd., Polyplus Transfection, and other market participants.
Purchase the latest in-depth report @ https://www.absolutemarketsinsights.com/checkout?id=363
Global Plasmid Market:
- By General Type Plasmid
- Conjugative
- Non-Conjugative
- By Specific Plasmid Types
- F-Plasmids
- Resistance Plasmids
- Virulence Plasmids
- Degradative Plasmids
- Col Plasmids
- Cryptic Plasmids
- By Application
- Transfection
- Gene Therapy
- Recombinant DNA Technology
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-740-024-2424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com
